The Limited Times

Now you can see non-English news...

Marie-Paule Kieny: "In this booster strategy, vaccines in the study phase will have their place"

2021-09-24T00:31:44.834Z


INTERVIEW - Virologist, vaccination specialist and public health expert, Marie-Paule Kieny is research director at Inserm. She chairs the Covid-19 Vaccine Committee.


LE FIGARO.

- Will the vaccines available to us be sufficient to vaccinate the entire planet?

To discover

  • Covid-19: what we know about the Delta variant

  • Covid-19: the third vaccine dose, instructions for use

Marie-Paule KIENY.

-

From a purely digital point of view Pfizer and Moderna ensure that they have sufficient production capacity to do so.

But by having only a few vaccines we run the risk of monopoly.

Read also

Are anti-Covid vaccines the cause of 25,000 deaths in Europe?

For the moment the manufacturers have agreed to restrict themselves during the pandemic, but have already started to increase their prices.

The production costs of an RNA vaccine do not exceed € 2.50 per dose, but they are already sold between € 15 and € 20.

Competition is the best tool to limit this increase.

There is therefore every interest in increasing the offer to guarantee access to as many people as possible.

These vaccines are extremely effective, is not any attempt at competition in vain?

RNA vaccines are great, but they are not very stable at room temperature.

Progress has been made, but storage conditions remain restrictive and complicate

This article is for subscribers only.

You have 52% left to discover.

Pushing back the limits of science is also freedom.

Continue reading your article for € 1 the first month

I ENJOY IT

Already subscribed?

Log in

Source: lefigaro

All tech articles on 2021-09-24

You may like

Life/Entertain 2024-01-27T16:57:55.237Z
News/Politics 2024-02-15T06:00:59.458Z

Trends 24h

Latest

© Communities 2019 - Privacy

The information on this site is from external sources that are not under our control.
The inclusion of any links does not necessarily imply a recommendation or endorse the views expressed within them.